Literature DB >> 7200729

Ultrastructural evaluation of adenocarcinomas derived from apocrine glands of the anal sac associated with hypercalcemia in dogs.

D J Meuten, C C Capen, G J Kociba, D J Chew, B J Cooper.   

Abstract

Adenocarcinomas derived from apocrine glands of the anal sac and associated with persistent hypercalcemia in dogs were composed of tumor cells with numerous profiles of rough endoplasmic reticulum, clusters of free ribosomes, and a prominent Golgi apparatus. Neoplastic cells contained microtubules, microfilaments, tonofibrils, and had two types of electron-dense granules. Large lysosomelike dense bodies ranged from 0.6 to 2.2 microns in diameter and had a poorly delineated limiting membrane. Small granules (150-400 nm in diameter) had a sharply delineated limiting membrane with a narrow submembranous space and a homogeneous dense core. These smaller granules usually were located near the apexes of neoplastic cells, whereas the larger granules were situated near the base of cells. Apocrine cells in glands of the anal sac from control dogs that were in the secretory phase were columnar and had large dilated profiles of rough endoplasmic reticulum. Membranes of the endoplasmic reticulum fused with the plasmalemma and appeared to secrete their product directly into the lumens of acini, characteristic of merocrine secretion. Apical blebs of electron-lucent cytoplasm pinched off from nonneoplastic aprocine cells and were released into glandular lumens. Similar electron-lucent cytoplasmic blebs were present at the apexes of tumor cells. Myoepithelial cells were present between the epithelial cells and basement membrane in normal apocrine glands and were absent in neoplasms derived from these glands. Identification of the contents of the secretory-like granules in tumor cells and characterization of the hypercalcemic factor in the plasma or tumor tissue from dogs with this syndrome will help explain the pathogenesis of hypercalcemia associated with malignancy in animals and man.

Entities:  

Mesh:

Year:  1982        PMID: 7200729      PMCID: PMC1915999     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Hyperparathyroidism associated with malignant tumors of nonparathyroid origin.

Authors:  G S Omenn; S I Roth; W H Baker
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

2.  Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation.

Authors:  R P Knill-Jones; R M Buckle; V Parsons; R Y Calne; R Williams
Journal:  N Engl J Med       Date:  1970-03-26       Impact factor: 91.245

3.  Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases.

Authors:  D Powell; F R Singer; T M Murray; C Minkin; J T Potts
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

Review 4.  Fine structural alterations of parathyroid glands in response to experimental and spontaneous changes of calcium in extracellular fluids.

Authors:  C C Capen
Journal:  Am J Med       Date:  1971-05       Impact factor: 4.965

5.  Pseudohyperparathyroidism in the dog.

Authors:  C A Osborne; J B Stevens
Journal:  J Am Vet Med Assoc       Date:  1973-01-15       Impact factor: 1.936

6.  Ectopic secretion of parathyroid hormone by a renal adenocarcinoma in a patient with hypercalcaemia.

Authors:  R M Buckle; M McMillan; C Mallinson
Journal:  Br Med J       Date:  1970-12-19

7.  Production of parathyroid hormone by nonparthyroid tumors.

Authors:  L M Sherwood; J L O'Riordan; G D Aurbach; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1967-01       Impact factor: 5.958

8.  The comparative anatomy and pathology of anal glands. Arris and Gale lecture delivered at the Royal College of Surgeons of England on 25th February 1965.

Authors:  I McColl
Journal:  Ann R Coll Surg Engl       Date:  1967-01       Impact factor: 1.891

9.  Osteolytic sterol in human breast cancer.

Authors:  G S Gordon; R J Cantino; L Erhardt; J Hansen; W Lubich
Journal:  Science       Date:  1966-03-11       Impact factor: 47.728

10.  Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.

Authors:  A H Tashjian; E F Voelkel; L Levine; P Goldhaber
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  1 in total

1.  Hypercalcemia of malignancy: Hypercalcemia associated with an adenocarcinoma of the apocrine glands of the anal sac.

Authors:  D J Meuten; C C Capen; G J Kociba; B J Cooper
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.